About Atopalm
Overview
Atopalm (Korean: 아토팜) is a South Korean skincare brand developed by NEOPHARM Co., Ltd. Launched around 2000, the brand specializes in skin-barrier care for sensitive skin, with a particular focus on products for babies and children. Its identity is built around its proprietary MLE® (Multi-Lamellar Emulsion) technology 1.
The parent company, NEOPHARM, describes itself as a skin-science and derma-cosmetics company founded in 2000, with Atopalm serving as one of its principal brands.
Quick Facts
| Category | Information |
|---|---|
| Brand | Atopalm / 아토팜 |
| Country of origin | South Korea |
| Parent company | NEOPHARM Co., Ltd. |
| Founded/Launched | 2000 |
| Category | Sensitive-skin / Derma-cosmetics |
| Core focus | Skin-barrier protection and moisturization |
| Signature technology | MLE® — Multi-Lamellar Emulsion |
| Main consumers | Babies, children, adults with sensitive or dry skin |
| Notable products | MLE Cream, MLE Lotion, Top to Toe Wash |
| Major positioning | Family-oriented sensitive-skin care |
| K-BPI recognition | No. 1 in Korea’s sensitive-skincare category for 19 consecutive years (per NEOPHARM) |
| Parent-company listing | KOSDAQ, ticker 092730 |
Brand Name and Meaning
The name Atopalm is a combination of two elements:
- ATO: Referring to sensitive skin.
- PALM: Representing a caring hand or palm.
According to the brand’s narrative, Atopalm originated from a researcher’s concern for his child who suffered from sensitive skin. This story forms a core part of the brand’s identity, symbolizing the intersection of scientific research and parental care 1. Consequently, Atopalm has historically positioned itself differently from conventional cosmetic brands; rather than emphasizing beauty, fragrance, or anti-aging, its central narrative focuses on protecting and supporting vulnerable skin.
History
Atopalm emerged alongside NEOPHARM’s early research into skin-barrier science.
Early Development
NEOPHARM was established in July 2000, and Atopalm was launched later that year. The brand’s initial flagship product was the MLE Cream. Historical materials describe the development of pseudo-ceramide and MLE technology as foundational to Atopalm, with subsequent expansion into clinical testing, publications, and patents 2.
Key Milestones
- 2000: NEOPHARM founded; Atopalm launched.
- 2002: Clinical results presented at the World Congress of Dermatology in France; safety testing conducted.
- 2003: Research on MLE structural properties published in the Journal of Investigative Dermatology.
- 2007: International expansion included a launch on QVC Japan; NEOPHARM became listed on KOSDAQ 3.
- 2008: Entry into the U.S. market through CVS.
- 2012: U.S. distribution expanded to ULTA.
- 2013: Expansion beyond skincare into household/life-care products; began product donations for children in need.
- 2021: Atopalm MLE Cream received Korean MFDS functional-cosmetic approval in the skin-barrier-recovery category (review completed October 25, 2021).
- 2023: Life-hygiene range expanded to include laundry detergent, fabric softener, and dish detergent.
- 2025: NEOPHARM reported Atopalm as No. 1 in the sensitive-skincare category of the Korea Brand Power Index for the 19th consecutive year.
MLE® Technology
The defining technical concept associated with Atopalm is MLE®, or Multi-Lamellar Emulsion.
The outermost layer of healthy skin contains lipids—specifically ceramides, cholesterol, and fatty acids—arranged in organized lamellar structures. NEOPHARM developed MLE to reproduce a structure resembling these natural skin-barrier lipid arrangements 1. In simplified terms, the approach aims to support the chain: Healthy skin barrier → organized lipid layers → reduced moisture loss.
Atopalm’s formulations are designed so that Ceramides + cholesterol + fatty acids create an MLE® lamellar structure that supports moisturization and barrier function. NEOPHARM describes MLE as its proprietary technology for reproducing the multi-lamellar structure of the skin barrier. It is distinct from simply adding ceramides; it refers to the specific formulation structure in which lipid components are organized to mimic the skin’s architecture.
Brand Philosophy
Atopalm’s philosophy rests on three pillars:
Skin-Barrier Science
The brand focuses on the relationship between skin-barrier condition and sensitivity, treating moisturization as a physiological necessity rather than merely a cosmetic effect 1.
Low-Irritation Formulation
Atopalm emphasizes ingredient selection, formulation, and safety testing specifically tailored for sensitive skin. The company positions its products for delicate young skin as well as adults 4.
Whole-Family Care
Rather than limiting itself to infant skincare, Atopalm has developed a product ecosystem spanning newborns, children, mothers, and adults, including cleansing and household hygiene items.
Product Portfolio
The current Korean portfolio is organized by life stage and specific needs.
Atopalm Baby
Designed for infant and young children’s skin, particularly addressing vulnerabilities due to developing skin barriers 1. Typical products include:
- MLE Cream
- MLE Lotion
- Top to Toe Wash
- Cleansers and bath products
- Various moisturizing products
Atopalm Kids
Formulated for growing children, addressing changing moisture and oil balance.
Atopalm Maternity
A line targeting skincare during pregnancy and the postpartum period, when users may experience changes in skin condition.
Life / Safety
Products intended to support everyday hygiene for children and households, including laundry detergent, fabric softener, and dish detergent.
MLE Cream
Often considered the signature product, the MLE Cream is closely associated with the brand’s MLE® technology and skin-barrier positioning. It notably received 2021 Korean MFDS functional-cosmetic approval concerning skin-barrier recovery.
MLE Lotion
Utilizing the same skin-barrier technology concept in a lighter format, the MLE Lotion is positioned as an everyday moisturizer for sensitive skin and family use.
Top to Toe Wash
A recognizable cleansing product that extends the brand’s sensitive-skin care strategy beyond leave-on moisturizers.
Scientific and Dermatological Positioning
Atopalm is best understood as a barrier-focused derma-cosmetic brand rather than solely a baby skincare brand. Its parent company, NEOPHARM, operates research activities through its CRID Center. As of September 2026, NEOPHARM reports 87 registered patents and 84 research papers linked to its research efforts. This scientific foundation is a key component of the brand’s differentiation.
Sensitive Skin Approach
The central problem Atopalm addresses is the link between a compromised skin barrier and sensitive, dry, or uncomfortable skin. The brand’s model suggests that supporting the skin barrier reduces moisture loss, improves hydration, and helps skin remain comfortable and resilient. Communication tends to emphasize barrier function, ceramides, lamellar structures, moisturization, and low irritation rather than aggressive active ingredients.
It is important to note that Atopalm is a cosmetic/derma-cosmetic brand; individual products should not automatically be regarded as medical treatments for conditions such as atopic dermatitis.
Safety Philosophy
Atopalm emphasizes a low-irritation approach, particularly because many products are intended for babies and children. The company states that ingredient selection and formulation are accompanied by safety testing 4. Older materials described formulations developed without several ingredients, including parabens, ethanol, PEG, mineral oil, and colorants. However, formulations can change over time, so current product ingredient lists should be checked individually.
International Presence
Although fundamentally a Korean brand, Atopalm has maintained an international presence for many years. Documented expansions include markets in:
- Japan
- United States
- China
- Russia
- Other overseas markets
The brand entered U.S. retail through CVS in 2008 and expanded to ULTA in 2012. NEOPHARM currently states that its brands have expanded to markets globally through exports and partnerships.
Reputation in South Korea
A notable claim regarding Atopalm’s reputation is its performance in the Korea Brand Power Index (K-BPI). NEOPHARM reports that Atopalm ranked No. 1 in the sensitive-skincare category for 19 consecutive years, as of 2025. This indicates a strong domestic association with sensitive-skin care in the Korean market, rather than being solely an export-oriented K-beauty brand.
Corporate Ownership
Atopalm is a brand owned by NEOPHARM Co., Ltd.
NEOPHARM was established on July 1, 2000, is headquartered in Daejeon, South Korea, and is listed on KOSDAQ under ticker 092730. The company also owns other brands including REALBARRIER, ZEROID, DERMA:B, and T’else. The corporate relationship is structured as NEOPHARM → Atopalm, meaning Atopalm is not an independent cosmetics company.
Sustainability and Social Initiatives
Atopalm operates the I Love Green campaign, connecting children’s welfare with environmental awareness. Activities include:
- Donations of products to children in vulnerable circumstances.
- Environmental education and children’s drawing contests.
- Eco-conscious packaging initiatives.
- Support for children in care facilities, single-mother shelters, and pediatric burn centers.
NEOPHARM reports that more than 338,000 products had been delivered to children in need through these initiatives since 2013.
Overall Brand Identity
Atopalm’s positioning can be summarized as: Korean + sensitive skin + skin-barrier science + family care + MLE technology.
Unlike many K-beauty brands that rely on trends or rapidly changing concepts, Atopalm has maintained a consistent proposition: scientifically studying sensitive skin to create gentle products that support the skin barrier. Its primary differentiator is the combination of sensitive-skin specialization, MLE® formulation technology, a long research history, and a family-oriented product ecosystem.





